This seminar / workshop will examine the existing and proposed requirements for the U.S. FDA's DHF -- including its derivative documents, the DMR and DHR.
John Roberts has 20 years of experience in business intelligence and management reporting, including 10 years specifically in BI. He has worked for companies like Sprint-Nextel and MedCenter Direct in reporting manager and product analyst roles. He holds an MBA from Georgia Tech with a concentration in IT. Based on his resume, he has expertise in areas like BI application planning, requirements gathering, deployment processes, and consulting approaches focused on primary research, data warehousing, and strategy. One of his work examples involved improving a metric for early life customer churn to make it more current, easily understood, and actionable.
Erica has over 15 years of experience in technical support roles providing help desk support, troubleshooting, and training. She has strong skills in Microsoft Office, Windows operating systems, and remote access tools like Citrix and VPN. Erica is detail-oriented, adapts well to change, and able to work independently to resolve issues. She has experience supporting both internal and external users at organizations like Bloomberg, Wells Fargo, and The World Bank Group.
Design controls are not an easy subject to address during and after the design of medical devices and manufacturing processes. Design controls should drive the device design process, not be an afterthought. This session focuses on treating design as a separate entity within the quality management system, user needs vs. design inputs, continuation of design controls after the transfer process, design review and more.
FDA Design Controls: What Medical Device Makers Need to KnowGreenlight Guru
The document provides an overview of a presentation on FDA Design Controls. It introduces the two presenters, David Amor and Jon Speer, who are experts in medical device quality systems and design controls. The presentation will cover topics related to design controls regulations, including intended use, user needs, design inputs, design reviews, risk management, design outputs, design verification and validation, and regulatory submissions. It is meant to help medical device companies understand and comply with FDA design control requirements.
The document discusses design controls, which are a set of quality practices and procedures incorporated into the design and development process to control the design process and ensure medical device specifications meet user needs and intended use. It provides an overview of the seven key elements of design controls according to FDA regulations: design and development planning, design input, design output, design review, design verification, design validation, and design changes. It emphasizes that design controls are important for medical device safety and quality.
Writing SOPs or procedural documents can be challenging at times. However, writing SOPs is overall a straightforward process. However, enforcing what you already created and implemented in the pipeline is another story.
We have all heard of Data Integrity but do you really understand what it is? Do you understand how 21 CFR 11 and Annex 11 fit into this picture? Specifically, can you answer questions on the following
John Roberts has 20 years of experience in business intelligence and management reporting, including 10 years specifically in BI. He has worked for companies like Sprint-Nextel and MedCenter Direct in reporting manager and product analyst roles. He holds an MBA from Georgia Tech with a concentration in IT. Based on his resume, he has expertise in areas like BI application planning, requirements gathering, deployment processes, and consulting approaches focused on primary research, data warehousing, and strategy. One of his work examples involved improving a metric for early life customer churn to make it more current, easily understood, and actionable.
Erica has over 15 years of experience in technical support roles providing help desk support, troubleshooting, and training. She has strong skills in Microsoft Office, Windows operating systems, and remote access tools like Citrix and VPN. Erica is detail-oriented, adapts well to change, and able to work independently to resolve issues. She has experience supporting both internal and external users at organizations like Bloomberg, Wells Fargo, and The World Bank Group.
Design controls are not an easy subject to address during and after the design of medical devices and manufacturing processes. Design controls should drive the device design process, not be an afterthought. This session focuses on treating design as a separate entity within the quality management system, user needs vs. design inputs, continuation of design controls after the transfer process, design review and more.
FDA Design Controls: What Medical Device Makers Need to KnowGreenlight Guru
The document provides an overview of a presentation on FDA Design Controls. It introduces the two presenters, David Amor and Jon Speer, who are experts in medical device quality systems and design controls. The presentation will cover topics related to design controls regulations, including intended use, user needs, design inputs, design reviews, risk management, design outputs, design verification and validation, and regulatory submissions. It is meant to help medical device companies understand and comply with FDA design control requirements.
The document discusses design controls, which are a set of quality practices and procedures incorporated into the design and development process to control the design process and ensure medical device specifications meet user needs and intended use. It provides an overview of the seven key elements of design controls according to FDA regulations: design and development planning, design input, design output, design review, design verification, design validation, and design changes. It emphasizes that design controls are important for medical device safety and quality.
Writing SOPs or procedural documents can be challenging at times. However, writing SOPs is overall a straightforward process. However, enforcing what you already created and implemented in the pipeline is another story.
We have all heard of Data Integrity but do you really understand what it is? Do you understand how 21 CFR 11 and Annex 11 fit into this picture? Specifically, can you answer questions on the following
why FDA at my Facility is, and what do I do During an InspectionGlobalCompliancePanel
Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer.
Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer.
The document announces a two-day in-person seminar on preparing for and responding to FDA inspections. The seminar will be held on July 21st and 22nd, 2016 in Cape Town, South Africa and led by regulatory expert David Dills. It will provide fundamentals and best practices for interacting with inspectors, ensuring documentation is in order, responding to inspection findings, and achieving favorable outcomes. Topics include inspection preparation and training, documentation requirements, dos and don'ts for interacting with investigators, and following up after inspections.
We have all heard of Data Integrity but do you really understand what it is? Do you understand how 21 CFR 11 and Annex 11 fit into this picture? Specifically, can you answer questions on the following:
The Challenges of an Effective Change Control Program and How to Address OOS ...GlobalCompliancePanel
An effective quality system program, along with several regulatory requirements, includes the documentation and evaluation of changes made to validated equipment, utilities, processes and controlled documents.
Why should you attend:
Understand Verification and Validation, differences and how they work together
Develop a "Working Definition" of V&V, Qualification, and related terms
Discuss recent regulatory expectations
Software Verification & Validation requirements of the FDA and ISO.
The latest FDA Software Guidance & Regulations, including Part 11 -impact on V&V strategies
Device and Manufacturing software requirements for V & V
How to determine & demonstrate an appropriate V & V strategy
How to determine & handle software for different Levels of Concern
What V&V is required for 3rd Party software-custom and Off-the-shelf
Impact of FDA, Mobile APPS, Cyber Security, and software standards such as IEC 62304
What to look for during software vendor audits.
V & V documentation and level of detail required for device submissions.
How to document a "risk-based" rationale, and use it in a resource-constrained environment
Determine key "milestones" and "tasks" in a project as well as discussing audience related projects for discussion points
Design of experiments (doe) for process development and validationGlobalCompliancePanel
This document advertises a 2-day in-person seminar on design of experiments (DOE) for process development and validation to be held in Washington, DC. The seminar will be led by Jim Wisnowski and costs $1,495 per delegate. It will cover topics such as screening designs, response surface designs, and utilizing systematic understanding from DOE studies. Attendees will learn how to use DOE to identify critical process parameters and develop functional relationships between parameters and critical quality attributes.
the challenges of an effective change control program and how to address oos ...GlobalCompliancePanel
An effective quality system program, along with several regulatory requirements, includes the documentation and evaluation of changes made to validated equipment, utilities, processes and controlled documents.
This document summarizes a 2-day in-person seminar on documenting software for FDA submissions that will take place in San Francisco, CA. The seminar, led by Brian Shoemaker, will discuss how to reconcile agile development methods with regulatory documentation requirements. It will provide guidance on documenting requirements, design, tests, hazards, and traceability throughout development while maintaining an agile approach. Attendees will learn how to address reviews and approvals without slowing development and how to demonstrate traceability naturally. The seminar aims to show how properly applying agile principles within a quality system can satisfy regulators' expectations for well-documented products.
A management system, by definition, is a process by which a function or functions are carried out in an organization by a series of hierarchal documents that are prescriptive, and set a particular path on which the organization manages its day-to-day operations.
When medical device companies consider Agile development methods, they often run into the key criticism that Agile groups produce little to no documentation, and that Agile stands in contradiction to the lifecycle standards outlined in IEC 62304.
We have all heard of Data Integrity but do you really understand what it is? Do you understand how 21 CFR 11 and Annex 11 fit into this picture? Specifically, can you answer questions on the following:
Analytical and other equipment should be qualified and computer systems should be validated to demonstrate suitability for the intended use. Electronic records must comply with FDA Part 11 and EU/PICS GMP Annex 11 requirements to ensure data integrity, security and availability.
Applied statistics, with emphasis on verification, validation, and risk manag...GlobalCompliancePanel
The 2-day seminar explains how to apply statistics to manage risk in R&D, QA/QC, and Manufacturing, with examples derived mainly from the medical device design/manufacturing industry. The flow of topics over the 2 days is as follows:
In Guidance for Industry Process Validation: General Principle and Practices, process validation is defined as, ""...the collection and evaluation of data, from the process design stage through commercial production..
Development of a safety program to save costs, delayed schedules and the human cost of injury or death. Safety management guidelines and techniques for the engineering, construction, and scientific professions. Includes costs of preparing the necessary safety documentation.
The document discusses the benefits of attending the Australian HL7 Working Group Meeting. It notes that HL7 standards are important for international healthcare interoperability. The working group meetings provide opportunities to advance standards, gain expertise from international experts, train, network, and influence standards to meet local needs. The meetings include tutorials, topic discussions, and presentations over 5 days. Attending costs around $3000 typically but HL7 New Zealand members can receive up to $1000 in refunds to attend, with the goal of increasing New Zealand participation.
This interactive two-day course explores proven techniques for reducing costs associated with implementing, using, and maintaining computer systems in regulated environments.
This 3-day training event on human factors for medical devices will take place in Dublin, Ireland from October 6-8, 2015. It will provide comprehensive instruction on integrating human factors into the medical device development process to improve usability and streamline regulatory approval. Speakers will include experts from the FDA and industry who will discuss guidance, standards, and the FDA approval process. Attendees will learn methods for requirements analysis, formative testing, validation studies, and reporting to meet FDA expectations. They will also engage in workshops and Q&A sessions to discuss real-world applications and challenges. The goal is to help participants incorporate human factors best practices to bring new devices to market more efficiently.
New FDA FSMA Rules on the Sanitary Transportation of Human and Animal FoodsGlobalCompliancePanel
Transportation and Logistics food transportation food safety rules are currently being finalized by the U.S. Food and Drug Administration (FDA). Under congressional instructions, the Food Safety Modernization Act (FSMA) requires the FDA to establish rules to improve,
As defined by the Health Information Portability and Accountability Act (HIPAA), a Business Associate can be any organization or person working in association with or providing services to a Covered Entity who handles or discloses Protected Health Information (PHI) or Personal Health Records (PHR).
Registration
why FDA at my Facility is, and what do I do During an InspectionGlobalCompliancePanel
Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer.
Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer.
The document announces a two-day in-person seminar on preparing for and responding to FDA inspections. The seminar will be held on July 21st and 22nd, 2016 in Cape Town, South Africa and led by regulatory expert David Dills. It will provide fundamentals and best practices for interacting with inspectors, ensuring documentation is in order, responding to inspection findings, and achieving favorable outcomes. Topics include inspection preparation and training, documentation requirements, dos and don'ts for interacting with investigators, and following up after inspections.
We have all heard of Data Integrity but do you really understand what it is? Do you understand how 21 CFR 11 and Annex 11 fit into this picture? Specifically, can you answer questions on the following:
The Challenges of an Effective Change Control Program and How to Address OOS ...GlobalCompliancePanel
An effective quality system program, along with several regulatory requirements, includes the documentation and evaluation of changes made to validated equipment, utilities, processes and controlled documents.
Why should you attend:
Understand Verification and Validation, differences and how they work together
Develop a "Working Definition" of V&V, Qualification, and related terms
Discuss recent regulatory expectations
Software Verification & Validation requirements of the FDA and ISO.
The latest FDA Software Guidance & Regulations, including Part 11 -impact on V&V strategies
Device and Manufacturing software requirements for V & V
How to determine & demonstrate an appropriate V & V strategy
How to determine & handle software for different Levels of Concern
What V&V is required for 3rd Party software-custom and Off-the-shelf
Impact of FDA, Mobile APPS, Cyber Security, and software standards such as IEC 62304
What to look for during software vendor audits.
V & V documentation and level of detail required for device submissions.
How to document a "risk-based" rationale, and use it in a resource-constrained environment
Determine key "milestones" and "tasks" in a project as well as discussing audience related projects for discussion points
Design of experiments (doe) for process development and validationGlobalCompliancePanel
This document advertises a 2-day in-person seminar on design of experiments (DOE) for process development and validation to be held in Washington, DC. The seminar will be led by Jim Wisnowski and costs $1,495 per delegate. It will cover topics such as screening designs, response surface designs, and utilizing systematic understanding from DOE studies. Attendees will learn how to use DOE to identify critical process parameters and develop functional relationships between parameters and critical quality attributes.
the challenges of an effective change control program and how to address oos ...GlobalCompliancePanel
An effective quality system program, along with several regulatory requirements, includes the documentation and evaluation of changes made to validated equipment, utilities, processes and controlled documents.
This document summarizes a 2-day in-person seminar on documenting software for FDA submissions that will take place in San Francisco, CA. The seminar, led by Brian Shoemaker, will discuss how to reconcile agile development methods with regulatory documentation requirements. It will provide guidance on documenting requirements, design, tests, hazards, and traceability throughout development while maintaining an agile approach. Attendees will learn how to address reviews and approvals without slowing development and how to demonstrate traceability naturally. The seminar aims to show how properly applying agile principles within a quality system can satisfy regulators' expectations for well-documented products.
A management system, by definition, is a process by which a function or functions are carried out in an organization by a series of hierarchal documents that are prescriptive, and set a particular path on which the organization manages its day-to-day operations.
When medical device companies consider Agile development methods, they often run into the key criticism that Agile groups produce little to no documentation, and that Agile stands in contradiction to the lifecycle standards outlined in IEC 62304.
We have all heard of Data Integrity but do you really understand what it is? Do you understand how 21 CFR 11 and Annex 11 fit into this picture? Specifically, can you answer questions on the following:
Analytical and other equipment should be qualified and computer systems should be validated to demonstrate suitability for the intended use. Electronic records must comply with FDA Part 11 and EU/PICS GMP Annex 11 requirements to ensure data integrity, security and availability.
Applied statistics, with emphasis on verification, validation, and risk manag...GlobalCompliancePanel
The 2-day seminar explains how to apply statistics to manage risk in R&D, QA/QC, and Manufacturing, with examples derived mainly from the medical device design/manufacturing industry. The flow of topics over the 2 days is as follows:
In Guidance for Industry Process Validation: General Principle and Practices, process validation is defined as, ""...the collection and evaluation of data, from the process design stage through commercial production..
Development of a safety program to save costs, delayed schedules and the human cost of injury or death. Safety management guidelines and techniques for the engineering, construction, and scientific professions. Includes costs of preparing the necessary safety documentation.
The document discusses the benefits of attending the Australian HL7 Working Group Meeting. It notes that HL7 standards are important for international healthcare interoperability. The working group meetings provide opportunities to advance standards, gain expertise from international experts, train, network, and influence standards to meet local needs. The meetings include tutorials, topic discussions, and presentations over 5 days. Attending costs around $3000 typically but HL7 New Zealand members can receive up to $1000 in refunds to attend, with the goal of increasing New Zealand participation.
This interactive two-day course explores proven techniques for reducing costs associated with implementing, using, and maintaining computer systems in regulated environments.
This 3-day training event on human factors for medical devices will take place in Dublin, Ireland from October 6-8, 2015. It will provide comprehensive instruction on integrating human factors into the medical device development process to improve usability and streamline regulatory approval. Speakers will include experts from the FDA and industry who will discuss guidance, standards, and the FDA approval process. Attendees will learn methods for requirements analysis, formative testing, validation studies, and reporting to meet FDA expectations. They will also engage in workshops and Q&A sessions to discuss real-world applications and challenges. The goal is to help participants incorporate human factors best practices to bring new devices to market more efficiently.
New FDA FSMA Rules on the Sanitary Transportation of Human and Animal FoodsGlobalCompliancePanel
Transportation and Logistics food transportation food safety rules are currently being finalized by the U.S. Food and Drug Administration (FDA). Under congressional instructions, the Food Safety Modernization Act (FSMA) requires the FDA to establish rules to improve,
As defined by the Health Information Portability and Accountability Act (HIPAA), a Business Associate can be any organization or person working in association with or providing services to a Covered Entity who handles or discloses Protected Health Information (PHI) or Personal Health Records (PHR).
Registration
This document advertises a 2-day in-person seminar on statistical methods and data visualization techniques. It will be held on August 3rd-4th in Raleigh, NC and taught by James Wisnowski. Attendees will learn how to explore and communicate data visually using software like Excel, R, Tableau, and JMP. The seminar agenda covers topics like univariate and multivariate plots, interactive graphs, best practices in data visualization, and more. Early registration saves $200 off the $1,295 individual price. Group discounts are also available for multiple attendees.
EMA has a 20-year track record of ensuring efficacy and safety of human and veterinary medicines across Europe, and promoting research and innovation in the development of medicines. In its first two decades, the Agency recommended the authorization of a total of 975 human and 188 veterinary medicines.
14 new fda fsma rules on the sanitary transportation of human and animal foodsGlobalCompliancePanel
This document summarizes a 2-day in-person seminar on the new FDA FSMA rules for sanitary transportation of food. The seminar will be held on August 17-18, 2017 in Raleigh, NC and cover topics such as definitions and responsibilities under the new rules, adulteration prevention, standards for management, sanitation and training, and how to develop a compliant transportation plan. Attendees will include food shippers, carriers, receivers, importers, handlers, logistics and food safety professionals. Discounts are available for multiple attendees registered together.
13 european regulatory procedures comprehensive overview of ema and national...GlobalCompliancePanel
EMA has a 20-year track record of ensuring efficacy and safety of human and veterinary medicines across Europe, and promoting research and innovation in the development of medicines. In its first two decades, the Agency recommended the authorization of a total of 975 human and 188 veterinary medicines
The secret is - HIPAA Rules are easy and routine to follow - when they are explained step-by-step in plain language. In this seminar Paul Hales will capture your attention with visual presentations, discussion and learning exercises and show how to find the right rule with the step-by-step procedures you need when you need them.
If you go "off label" with advertising and promotion, FDA's hammer can hit hard and seemingly out of the blue. Advertising and promotion for devices is weak and lacks legal clarity. For drugs, the regulations are prescriptive and guidance documents clamp down on nuances.
As defined by the Health Information Portability and Accountability Act (HIPAA), a Business Associate can be any organization or person working in association with or providing services to a Covered Entity who handles or discloses Protected Health Information (PHI) or Personal Health Records (PHR).
An essential task in any compliance analytics workflow is to not only explore your data visually, but also to communicate your results professionally with graphic displays. Do you have the tools and skills to quickly and thoroughly perform these tasks?
This course will provide attendees with a concise but comprehensive overview of all relevant regulatory, technical and quality elements necessary to assure successful market access. This includes
What to expect in a federal hipaa audit & how to avoid auditGlobalCompliancePanel
I will be speaking to real life audits conducted by the Federal government for Phase 2 and beyond (I've been on both sides of these audits) what your highest risks are for being fined (some of the risk factors may surprise you).
This course covers a very broad range of topics from worker classification, to employee classification, to establishing methods and rates of pay, what must be included in the rate of pay, hours that must be compensated as worked time, required benefits, de minimus working fringes,
If statistical analysis is not properly performed and/or understood, a firm can run the risk of distributing the kind of product to the market that ultimately fails, resulting in lost time and money. Statistics of course, requires constant practice.
Modern hipaa compliance managing privacy, security, and breach notification...GlobalCompliancePanel
Day one sets the stage with an overview of the HIPAA regulations including HIPAA Breach Notification and the process that must be used to determine whether or not a breach is reportable, and then continues with presentation of the specifics of the Privacy Rule, recent changes to the rules, and the basics of the Security Rule.
This lesson will be addressing how practice/business managers (or compliance offers) need to get their HIPAA house in order before the imminent audits occur. It will also address major changes under the Omnibus Rule and any other applicable updates for 2016.
Laboratory, medical and device performance and validation following regulator...GlobalCompliancePanel
Too often, we focus on getting things done and results and miss working on our self-development. Let's face it: this is how we get paid yet this is also how we keep falling behind when it comes to our careers. It's time to get ahead! Don't miss an opportunity to advance as a manager again!
This document advertises a 2-day in-person seminar on incorporating risk management into HR policies taking place on July 27-28, 2017 in Philadelphia. The seminar, led by Ronald L. Adler, an HR consultant with over 40 years of experience, will cover topics such as conducting HR audits, assessing human capital risks, developing HR metrics, and the components of an HR audit model. Attendees will receive a participation certificate, seminar materials, and special access to future seminars and consulting services. Group discounts are available for multiple attendees.
HR audits are designed to help your organization focus its attention on its human resource management practices, policies, procedures, processes, and outcomes by providing you with a structured and systematic series of questions about key compliance,
Fda's gmp expectations for phase i and first in-man clinical trialsGlobalCompliancePanel
Early clinical trials are conducted to establish initial safety of a drug. The studies are generally in small number of healthy subjects and use lower doses of the drug product. Therefore, only small amounts of investigational material are required.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Co-Chairs, Val J. Lowe, MD, and Cyrus A. Raji, MD, PhD, prepared useful Practice Aids pertaining to Alzheimer’s disease for this CME/AAPA activity titled “Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neuroradiology in Diagnosis and Treatment.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3PvVY25. CME/AAPA credit will be available until June 28, 2025.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...AyushGadhvi1
learning occurs when a stimulus (unconditioned stimulus) eliciting a response (unconditioned response) • is paired with another stimulus (conditioned stimulus)
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Dhf technical-file-las-vegas
1. 2-day In-person Seminar:
Knowledge, a Way Forward…
The DHF, Technical File and Design Dossier -
Similarities, Differences and The Future
Las Vegas, NV
March 2nd & 3rd, 2017
9:00 AM to 6:00 PM
John E Lincoln
Price: $1,295.00
(Seminar for One Delegate)
Register now and save $200. (Early Bird)
**Please note the registration will be closed 2 days
(48 Hours) prior to the date of the seminar.
Price
Overview :
Global
CompliancePanel
John E Lincoln is Principal of J. E. Lincoln and
Associates LLC, a consulting company. John, a graduate of UCLA,
is a medical device and Regulatory Affairs consultant. He has
helped companies to implement or modify their GMP systems and
procedures, product risk management and U.S. FDA responses. In
addition, he has successfully designed, written and run all types of
process, equipment and software qualifications/validations, which
have passed FDA audit or submission scrutiny, and have been
described in peer-reviewed technical articles and workshops
worldwide.
We will consider the following:
The Design Control requirements of the CGMPs, 21 CFR 820.30
The Design History File - documenting Product Design Control and
its nine elements
The Device Master Record and the Device History Record
The EU's Medical Device Directive
The "Essential Requirements"; and their documentation
The remaining elements of a Technical File / Design Dossier
Trends
Two attendee projects
$6,475.00
Price: $3,885.00 You Save: $2,590.0 (40%)*
Register for 5 attendees
Consultant, Medical device and Regulatory affairs
2. Global
CompliancePanel
Agenda:
Day One Day Two
Lecture 1: The Design Control requirements of the CGMPs,
21 CFR 820.30
2-day In-person Seminar:
The DHF, Technical File and Design Dossier -
Similarities, Differences and The Future
Why you should attend Who Will Benefit:
Lecture 2: The Design History File - documenting Product
Design Control and its nine elements
Lecture 3: The Device Master Record and the Device
History Record
Lecture 4: Summary of morning discussion
This seminar / workshop will examine the existing
and proposed requirements for the U.S. FDA's DHF -
- including its derivative documents, the DMR and
DHR. It will consider the European Union's MDD
TF/DD requirements, and evaluate the documents'
differing purposes / goals, their similarities, as well as
the two different device classification schemes.
Required and desirable contents will be discussed.
Also considered: Areas requiring frequent re-
evaluation / update; Similarities and differences;
Future trends; Typical DHF Table of Contents;
Technical File or Design Dossier Table of Contents;
The importance and usefulness of the "Essential
Requirements"; Structure of the "Declaration of
Conformity"; self-declaring or Notified-Body reviewed;
Parallel approaches to development.
Lecture 5: Group activity on the 1) The DHF, or 2) The DMR
and DHRs
Senior and middle management and staff
Regulatory Affairs
QA/QC
R&D
Production Management
Manufacturing Engineers
Process Engineers
Project Managers
Vendors, sales and marketing
Any tasked with medical device development,
documentation, and regulatory responsibilities
Lecture 6: Review of group activity and Q&A
Lecture 1: The EU's Medical Device Directive
Lecture 2: The "Essential Requirements" and their
documentation
Lecture 3: The remaining elements of a Technical File /
Design Dossier
Lecture 4: ISO 14971:2012, The Product Risk Management
File / Report overview
Lecture 5: DHF / TF, DD Trends
Lecture 6: Summary of morning discussion
Lecture 7: Group activity on 1) The Technical File / Design
Dossier, or 2) Essential Requirements
Lecture 8: Review of group activity and Q&A
Lecture 9: Summary of morning discussion
Lecture10: Course summary discussion
3. Global
CompliancePanel
www.globalcompliancepanel.com
Kindly get in touch with us for any help or
information.
Look forward to meeting you at the seminar
GlobalCompliancePanel
What You will get
Special price on future seminars by
GlobalCompliancePanel.
Networking with industry's top notch professionals
7
9
1 Learning Objectives
2 Participation certificates
Interactive sessions with the US expert
Post event email assistance to your queries.
Special price on future purchase of web
based trainings.
Special price on future consulting or expertise
services.
3
4
5
6
Seminar Kit – includes presentation handout,
ID card, brochure, trainings catalog, notepad
and pen.
8
Contact Information: Event Coordinator
NetZealous LLC, DBA GlobalCompliancePanel
161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA
Toll free: +1-800-447-9407
Fax: 302 288 6884
Email: support@globalcompliancepanel.com
10%
20%
25%
30%
2 Attendees to get offer
3 to 6 Attendees to get offer
7 to 10 Attendees to get offer
10+ Attendees to get offer
Group Participation
Payment Option
1 Credit Card: Use the Link to make Payment by
Visa/Master/American Express card click on the
register now link
2 Check: Kindly make the check payable to
NetZealous DBA GlobalCompliancePanel and
mailed to 161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA
PO: Please drop an email to
support@globalcompliancepanel.com or call the
our toll free +1-800-447-9407 for the invoice and
you may fax the PO to 302 288 6884
Wire Transfer: Please drop an email to
support@globalcompliancepanel.com or call our
toll free +1-800-447-9407 for the wire transfer
information
3
4
2-day In-person Seminar:
The DHF, Technical File and Design Dossier -
Similarities, Differences and The Future